| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Cash from Operating Activity+ | 33290.50 | 50164.80 | 23867.50 | 24345.20 | 39246.20 |
| Cash from Investing Activity | 5986.90 | -32115.60 | -39777.50 | -42559.50 | -18758.00 |
| Cash from Financing Activity | -13649.40 | -29692.70 | 18144.10 | 8004.20 | 1197.80 |
| Net Cash Flow | 25628.00 | -11643.50 | 2234.10 | -10210.10 | 21686.00 |
| Opening Cash & Cash Equivalents | 27468.20 | 53299.10 | 41625.10 | 43922.70 | 33854.30 |
| Closing Cash & Cash Equivalents | 53299.10 | 41625.10 | 43922.70 | 33854.30 | 55637.90 |
| In Rs. Cr. | 2023-09 | 2023-12 | 2024-03 | 2024-06 |
|---|---|---|---|---|
| Net Sales | 7219.42 | 7351.78 | 7580.15 | 7567.02 |
| Expenditure+ | 5845.98 | 5750.47 | 5907.34 | 5947.45 |
| Other Income+ | 186.98 | 162.52 | 135.62 | 220.93 |
| Operating Profit | 1373.44 | 1601.31 | 1672.81 | 1619.57 |
| Interest | 68.18 | 75.55 | 89.43 | 111.04 |
| Depreciation and Amortization | 417.50 | 423.27 | 354.33 | 404.18 |
| Profit Before Tax | 1075.64 | 1262.42 | 1229.90 | 1323.89 |
| Tax+ | 323.70 | 322.45 | 322.55 | 405.67 |
| Net Profit | 751.94 | 939.97 | 907.35 | 918.22 |
Failed to load balance sheet data
Failed to load peer comparison data
No corporate actions available for this company
Failed to load profit & loss data
Failed to load shareholding pattern
₹1579.35
+ 3.90 (0.25%)
04:01 pm - close price
BSE: AUROPHARMA
NSE: AUROPHARMA
Industry: Pharmaceuticals & Drugs
House: Aurobindo